Cargando…
Development of a Novel DNA Oligonucleotide Targeting Low-Density Lipoprotein Receptor
Low-density lipoprotein receptor (LDL-R) is a cell surface receptor protein expressed in a variety of solid cancers, including lung, colon, breast, brain, and liver, and therefore it opens up opportunities to deliver lysosome-sensitive anti-cancer agents, especially synthetic nucleic acid-based ther...
Autores principales: | Wang, Tao, Rahimizadeh, Kamal, Veedu, Rakesh N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920325/ https://www.ncbi.nlm.nih.gov/pubmed/31841991 http://dx.doi.org/10.1016/j.omtn.2019.11.004 |
Ejemplares similares
-
Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
por: Chen, Suxiang, et al.
Publicado: (2016) -
Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
por: Wang, Tao, et al.
Publicado: (2019) -
Evaluation of DNA segments in 2′-modified RNA sequences in designing efficient splice switching antisense oligonucleotides
por: Le, Bao T., et al.
Publicado: (2021) -
Recent Advances in Oligonucleotide Therapeutics in Oncology
por: Xiong, Haoyu, et al.
Publicado: (2021) -
Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide
Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
por: Le, Bao T., et al.
Publicado: (2020)